VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

被引:2857
作者
WEI, XP
GHOSH, SK
TAYLOR, ME
JOHNSON, VA
EMINI, EA
DEUTSCH, P
LIFSON, JD
BONHOEFFER, S
NOWAK, MA
HAHN, BH
SAAG, MS
SHAW, GM
机构
[1] UNIV ALABAMA,DIV HEMATOL ONCOL,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,DIV INFECT DIS,BIRMINGHAM,AL 35294
[3] MERCK SHARP & DOHME LTD,RES LABS,DEPT ANTIVIRAL RES,W POINT,PA 19486
[4] MERCK SHARP & DOHME LTD,RES LABS,DEPT CLIN PHARMACOL,W POINT,PA 19486
[5] GENELABS TECHNOL INC,DIV HIV & EXPLORATORY RES,REDWOOD CITY,CA 94063
[6] UNIV OXFORD,DEPT ZOOL,OXFORD OX1 3PS,ENGLAND
基金
英国惠康基金;
关键词
D O I
10.1038/373117a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dynamics of HIV-1 replication in vivo are largely unknown yet they are critical to our understanding of disease pathogenesis. Experimental drugs that are potent inhibitors of viral replication can be used to show that the composite lifespan of plasma virus and virus-producing cells is remarkably short (half-life similar to 2 days). Almost complete replacement of wild-type virus in plasma by drug-resistant variants occurs after fourteen days, indicating that HIV-1 viraemia is sustained primarily by a dynamic process involving continuous rounds of de novo virus infection and replication and rapid cell turnover.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 44 条
  • [1] PLASMA HIV-1 VIREMIA IN HIV-1 INFECTED INDIVIDUALS ASSESSED BY POLYMERASE CHAIN-REACTION
    AOKISEI, S
    YARCHOAN, R
    KAGEYAMA, S
    HOEKZEMA, DT
    PLUDA, JM
    WYVILL, KM
    BRODER, S
    MITSUYA, H
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (07) : 1263 - 1270
  • [2] DYNAMICS OF MOLECULAR-PARAMETERS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY IN-VIVO
    BAGNARELLI, P
    VALENZA, A
    MENZO, S
    MANZIN, A
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (04) : 2495 - 2502
  • [3] MOLECULAR PROFILE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION IN SYMPTOMLESS PATIENTS AND IN PATIENTS WITH AIDS
    BAGNARELLI, P
    MENZO, S
    VALENZA, A
    MANZIN, A
    GIACCA, M
    ANCARANI, F
    SCALISE, G
    VARALDO, PE
    CLEMENTI, M
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (12) : 7328 - 7335
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS-1 (HIV-1)-SPECIFIC REVERSE-TRANSCRIPTASE (RT) INHIBITORS MAY SUPPRESS THE REPLICATION OF SPECIFIC DRUG-RESISTANT (E138K)RT HIV-1 MUTANTS OR SELECT FOR HIGHLY RESISTANT (Y181C-]C181I)RT HIV-1 MUTANTS
    BALZARINI, J
    KARLSSON, A
    SARDANA, VV
    EMINI, EA
    CAMARASA, MJ
    DECLERCQ, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) : 6599 - 6603
  • [5] CAO Y, IN PRESS AIDS RES HU
  • [6] HIGH TITERS OF CYTOPATHIC VIRUS IN PLASMA OF PATIENTS WITH SYMPTOMATIC PRIMARY HIV-1 INFECTION
    CLARK, SJ
    SAAG, MS
    DECKER, WD
    CAMPBELLHILL, S
    ROBERSON, JL
    VELDKAMP, PJ
    KAPPES, JC
    HAHN, BH
    SHAW, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 954 - 960
  • [7] COFFIN JM, 1992, CURR TOP MICROBIOL, V176, P143
  • [8] INCREASED VIRAL BURDEN AND CYTOPATHICITY CORRELATE TEMPORALLY WITH CD4+ T-LYMPHOCYTE DECLINE AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED INDIVIDUALS
    CONNOR, RI
    MOHRI, H
    CAO, YZ
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (04) : 1772 - 1777
  • [9] PLASMA VIREMIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTION
    COOMBS, RW
    COLLIER, AC
    ALLAIN, JP
    NIKORA, B
    LEUTHER, M
    GJERSET, GF
    COREY, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1626 - 1631
  • [10] TRANSIENT HIGH-LEVELS OF VIREMIA IN PATIENTS WITH PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    DAAR, ES
    MOUDGIL, T
    MEYER, RD
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (14) : 961 - 964